来自SARS-CoV-2 Omicron BF.7变种RBD的抗体制备和免疫学分析

Quansheng Wang1, Chenyi Wang1, Zhicheng Zhang2

  • 1Institute of Pathogenic Microorganism, Jiangxi Agricultural University, Nanchang, Jiangxi 330045, China; Nanchang City Key Laboratory of Animal Virus and Genetic Engineering, Nanchang, Jiangxi 330045, China; College of Bioscience and Engineering, Jiangxi Agricultural University, Nanchang, Jiangxi 330045, China.

Molecular immunology
|October 8, 2025
PubMed
概括

研究人员成功地在E. coli中产生了SARS-CoV-2 Omicron BF.7尖端蛋白受体结合域 (RBD). 这种蛋白质引起强烈的免疫反应,有助于检测Omicron变种和疫苗开发.